• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1991 Fiscal Year Final Research Report Summary

Studies on hepatic resectability and the interruption of hepatic blood inflow in dogs with obstructive jaundice

Research Project

Project/Area Number 01480324
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Digestive surgery
Research InstitutionMie University

Principal Investigator

MIZUMOTO Ryuji  Mie University, Faculty of Medicine, Professor, 医学部, 教授 (00025561)

Co-Investigator(Kenkyū-buntansha) YOKOI Hajime  Mie University, Faculty of Medicine, University Hospital, Lecturer, 医学部附属病院, 講師 (60174843)
NOGUCHI Takashi  Mie University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (40144258)
KAWARADA Yoshifumi  Mie University, College of Medical Sciences, ProFessor, 医療技術短期大学部, 教授 (40024814)
Project Period (FY) 1989 – 1991
Keywordsfunctional resectabity of the liver / function of sinusoidal lining cell of the liver / hepatic artery interruption / major hepatic necrosis / portal stasis / ischemia-reperfusion injury / free radical / free radical scavenger
Research Abstract

Obstructive jaundice was produced in adult mongrel dogs by cholecystectomy and ligation-cut off of the di!ktal common bile duct, and the resectability and the tolerable limit of interruption of hepatic blood inflow in the liver with obstructive jaundice were functionally and morphologically evaluated.
(1) Resectability of the liver with obstructive jaundice : When hepatectomy was performed with choledochoduodenostomy 2 weeks after production of obstructive jaundice, the 4-week survival rate was : 71% after 40% hepatectomy and 22% after 70% hepatectomy, respectively. The IGGRmax value before hepatectomy clearly indicated the limit of one-staged hepatectomy. On the other hand, when the choledochoduodenostomy for reduction of jaundice prior to hepatectomy was performed 3 weeks after production of obstructive jaundice, followed by 70% hepatectomy, many dogs that received hepatectomy 2 weeks after choledochoduodenostomy died within 4 weeks after two-staged hepatectomy, because of the insuffi … More cient of the reticuloendothelial' system and the coagulation-fibrinolysis system even if the hepatic reserve had been restored above the critical level. The 4-week survival rate. in dogs that underwent hepatectomy 3 weeks after the choledochoduodenostomy was significantly better at 67%.
(2) Tolerable limit of interruption of the hepatic blood inflow : When the blood supply of the liver was interrupted simultaneously with choledochoduodenostomy 2 or 3 weeks after production of obstructive jaundice, the tolerable limits of interruption 2 and 3 weeks after production of, jaundice were 2 hours and I hour, respectively, in the hepatic artery, 20 and 10 minutes in the portal vein, and 10 and 5 minutes in both the hepatic artery and portal vein. The tolerable limit of interruption shortened as the duration of jaundice was longer. Especially, in the dogs that received interruption of the hepatic artery, the cause of death was extensive neurosis of the liver, and the choledochoduodenostomy was not effective even if those that survived, with electron microscopy suggesting significant prolongation of jaundice as compared with the dogs that received the choledochoduodenostomy alone.
(3) Hepatic resectability after interruption of the hepatic blood inflow and reperfusion : In dogs that received 40% hepatectomy and the choledochoduodenostomy after 5- or 10-minute simultaneous interruption of the hepatic artery and the portal vein followed by 60-minute reperfusion 2 or 3 weeks after production of obstructive jaundice, the 1-week survival rate was significantly lower than in those that received the choledochoduodenostomy alone (40% and 20% 2 and 3 weeks, respectively, after production of jaundice). In the former group, lipid peroxides levels of the liver tissue and blood of were increased at both times, respectively. However, the survival rate improved, and the liver injury was milder, when a free radical scavenger such us Coenzyme Q_<10>, Superoxide dismutase and so on was administered before interruption of the hepatic blood inflow. Less

  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Ryuji Mizumoto: "Surgical anatomy of the hapatic hilum with special reference to the caudate lobe" World J.Surg.12. 2-10 (1988)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水本 龍二: "臨床医学の展望ー肝、胆道、膵外科" 日本医事新報. 3380. 15-21 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水本 龍二: "胆道癌の治療ー現況と対策" 胆道. 3. 373-377 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水本 龍二: "肝臓外科における手術危険度と手術適応の拡大" 日本消化器外科学会誌. 23. 2175-2184 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水本 龍二: "胆管細胞癌" 肝胆膵. 21. 531-536 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水本 龍二: "胆嚢癌手術" 消化器外科. 14. 1233-1253 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水本 龍二: "肝疾患治療ハンドブック「肝切除の術前、術後管理の基本」" 南江堂, 10 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 水本 龍二: "外科学:肝臓ー解剖,生理,検査法" 朝倉書店, 15 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ryuji MIZUMOTO: "Surgical anatomy of the hepatic hilum with special reference to the caudate lobe" World J Surg. 12. 2-10 (1988)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ryuji MIZUMOTO: "The view of clinical medicine-surgery of the liver, biliary tract and pancreas" Japan Medical J. 3380. 15-21 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ryuji MIZUMOTO: "Present status of treatment for biliary tract cancer" J. Japan Biliary Association. 3. 373-377 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ryuji MIZUMOTO: "Preoperative estimation of operative risk and extension of operative indication in hepatic surgery" J. Japanese Gastroenterological Surg.23. 2175-2184 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ryuji MIZUMOTO: "Clinical problems on diagnosis and classification of cholangiocellular carcinoma of the liver, including cystic adenocarcinoma" KAN・TAN・SUI. 21. 531-536 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ryuji MIZUMOTO: "Operation for gall bladder carcinoma" Shokaki Geka. 14. 1233-1253 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ryuji MIZUMOTO: "Practical hand book. of treatment for liver diseases : Basic management before : and after hepatectomy" Nanko-do. 56-65 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ryuji MIZUMOTO: "Surgery : Liver-anatomy, Physiology and examination" Asakura-shoten. 3. 487-491

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi